Endometriosis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Endometriosis Clinical Trial Report Overview
A total of 812 Endometriosis clinical trials were conducted as of February 2024. The Endometriosis clinical trial report provides a comprehensive understanding of the Endometriosis clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor types and the prominent sponsors associated with the trials.
Key Regions | · North America
· Europe · Asia-Pacific · Middle East and Africa · South and Central America |
Key Countries | · China
· The US · Iran · Japan · Russia · India · Italy · Germany · The UK · Spain |
Key Sponsor Types | · Company
· Institution · Government |
Leading Sponsors | · AbbVie Inc
· Bayer AG · Ferring Holding SA · Neurocrine Biosciences Inc · Sumitomo Chemical Co Ltd |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Endometriosis Clinical Trials Segmentation by Regions and Countries
As of February 2024, Asia-Pacific led the Endometriosis clinical trials landscape with more than 35% of the clinical trials conducted there
The key regions considered for Endometriosis clinical trials analysis are North America, Europe, Asia-Pacific, the Middle East and Africa, and South and Central America.
In the country-wise analysis, China held the highest number of Endometriosis clinical trials as of February 2024. Germany had the highest average patient enrollment in Endometriosis clinical trials during the same time.
G7 countries: Among the G7 (United States, United Kingdom, Germany, France, Italy, Canada and Japan) countries, Japan has the highest proportion of Endometriosis to Women’s Health clinical trials as of February 2024.
E7 countries: Among the E7 (Brazil, Russia, India, China, Mexico, Turkey and Indonesia) countries, Indonesia has the highest proportion of Endometriosis to Women’s Health clinical trials as of February 2024.
Endometriosis Clinical Trials Analysis by Regions, 2024 (%)
Buy the Full Report for More Regional Insights into the Endometriosis Clinical Trials
Endometriosis Clinical Trials Segmentation by Sponsor Types
The key sponsor types for Endometriosis clinical trials are company, institution, and the government. As of February 2024, more than 49% of Endometriosis clinical trials conducted were sponsored by company sponsor type, followed by institution.
Endometriosis Clinical Trials Analysis by Sponsor Types, 2024 (%)
Buy the Full Report for More Sponsor Type Insights into the Endometriosis Clinical Trials
Endometriosis Clinical Trials - Competitive Landscape
In 2024, AbbVie Inc conducted the highest number of Endometriosis clinical trials
A few of the leading sponsors for Endometriosis clinical trials are:
- AbbVie Inc
- Bayer AG
- Ferring Holding SA
- Neurocrine Biosciences Inc
- Sumitomo Chemical Co Ltd
Endometriosis Clinical Trials Analysis by Sponsors, 2024 (%)
Buy the Full Report to Know More about the Leading Sponsors of Endometriosis Clinical Trials
Segments Covered in the Report
Endometriosis Clinical Trials Regional Outlook (2024)
- North America
- Europe
- Asia-Pacific
- Middle East and Africa
- South and Central America
Endometriosis Clinical Trials Country Outlook (2024)
- China
- The US
- Iran
- Japan
- Russia
- India
- Italy
- Germany
- The UK
- Spain
Endometriosis Clinical Trials Sponsor Type Outlook (2024)
- Company
- Institution
- Government
Scope
- The report provides a snapshot of the global clinical trials landscape.
- The report provides top-level data related to the clinical trials by region, country (G7 & E7), trial status, trial phase, sponsor type, and endpoint status.
- The report reviews the top companies involved and enlists all trials (trial title, phase, and status) of the company.
- The report provides all the unaccomplished trials (terminated, suspended, and withdrawn) with a reason for accomplishment.
- The report provides enrollment trends for the past five years.
- The report provides the latest news for the past three months.
Reasons to Buy
- Formulate key business strategies with regard to investment.
- Identify prominent locations for conducting clinical trials which saves time and cost.
- Get top level analysis of the Global Clinical Trials Market which helps in identifying key business opportunities.
- Understand trial count and enrollment trends by country in the global therapeutics market.
- Interpret the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended, or withdrawn) trials.
- Understand clinical trial assessment of the indication on a global, regional, and country level.
Bayer AG
Ferring Holding SA
Neurocrine Biosciences Inc
Sumitomo Chemical Co Ltd
Sumitomo Pharma Co Ltd
Takeda Pharmaceutical Co Ltd
Kissei Pharmaceutical Co Ltd
Pfizer Inc
Astellas Pharma Inc
Table of Contents
Table
Figures
Frequently asked questions
-
Which region accounted for the highest number of Endometriosis clinical trials in February 2024?
Asia-Pacific accounted for the highest number of Endometriosis clinical trials as of February 2024.
-
Which country conducted the highest number of Endometriosis clinical trials in January 2024?
China conducted the highest number of Endometriosis clinical trials as of February 2024.
-
Which sponsor type was the most prominent in the Endometriosis clinical trials in January 2024?
As of February 2024, most of the Endometriosis clinical trials conducted were sponsored by company sponsor type.
-
Which are the leading sponsors of Endometriosis clinical trials?
A few of the leading sponsors of Endometriosis clinical trials are AbbVie Inc, Bayer AG, Ferring Holding SA, Neurocrine Biosciences Inc, and Sumitomo Chemical Co Ltd among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.